Cimzia Side Effects

Name: Cimzia

Generic: Certolizumab Pegol

Manufacturer: UCB

Date approved: 2008

Status: Prescription Only - FDA Black Box Warning Label

Approved uses: Crohn's disease

Off-Label uses: None

Side effects:
  • Headache
  • upper respiratory infections
  • abdominal pain
  • injection site reactions and nausea. Serious Fungal Infection possibly resulting in death.
Related topics: Enbrel, Remicade, Humira


Cimzia (Certolizumab Pegol)

Cimzia (certolizumab pegol) is an immunosuppresant, approved by the FDA for the treatment of Crohn's disease, rheumatoid arthritis, and juvenile arthritis. It is administered through a subcutaneous injection.

The most common side effects of Cimzia are headache, upper respiratory infections, abdominal pain, injection site reactions and nausea. Patients taking Cimzia are at increased risk for serious adverse effects, including serious infections that can lead to hospitalization or death. Because Cimzia affects the immune system, it can lower the body's ability to fight infections, such as tuberculosis and other opportunistic infections. Cimzia is a blocker of TNF (tumor necrosis factor) and may cause lymphomas (a form of cancer) and other malignancies.

Recently, Cimzia was given a Black Box Label Warning by the FDA. The Black Box Warning is the strongest warning label a drug can have applied to it. Drugs that carry a high risk of serious side effects or potentially deadly adverse reactions are given this warning. This label is given only after medical studies have indicated that there are serious risks associated with the side effects of the medication.


Cimzia Linked to Life-Threatening Cancer Risk Among Children, Young Adults

Cimzia (certolizumab pegol) is an autoimmune disorder drug belonging to a family of drugs known as tumor necrosis factor (TNF) inhibitors. Recently, Cimzia, along with several other TNF blockers, were linked to an increased risk of cancer among patients taking the drug, specifically among young adults and children. Food and Drug Administration (FDA) launched an investigation into the TNF blockers after at least 30 cases of cancer among children consuming the drugs were reported during a ten-year period from 1998 to 2008, according to a September 2008 news article from Reuters . read more

Living With Crohn's Disease

Crohn's disease is a physical disorder in which the inflammation of the digestive system occurs. The Crohn's and Colitis Foundation of America (CCFA) has researched the potential causes of Crohn's disease and have found that while more research is necessary as to the specific reasons behind the condition, the following are factors that may contribute to an individual developing the condition: genes (a family's history of illnesses) an individuals immune system foreign substances such as antigens in the environment According to the CCFA, many scientists believe that "the interaction of an outside agent (such as a virus or bacterium) with the body's immune system may trigger the disease." Unfortunately, if an individual has a weakened immune system and they also have a family history of Crohnís disease or ulcerative coliti , they are at a high risk for developing the disease. Both males and females are equally affected and individuals between the ages of 15 and 35 make up most of the population of Crohn's disease sufferers , between 500,000 and 1 million Americans. read more

View the Cimzia Law Articles page here


Cimzia News Articles

2010Äê¶È»ñÅúµÄС·Ö×ÓÒ©ÎïÅ̵ã-ÉúÎïÒ½Ò©²úÒµ - ÉúÎï¹È

Article > NICE turns down B-MS' Orencia as second-line RA option

View the Cimzia News Articles page here


Cimzia Newsfeeds

FDA Continues Review of Cancer Risk Associated with TNF blockers, Azathioprine, and/or Mercaptopurine

FDA Warns Again of Lymphoma Risk With TNF Blockers in Teens

View the Cimzia Newsfeeds page here

Need A Cimzia Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Cimzia Case - Submit Your Information Below

Do you need legal assistance with your Cimzia case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Cimzia Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.